Drugs / Fluorescein Na
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03244982 | Apr 2018 → Jul 2019 | — | Kresge Eye Institute | Suspended | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluorescein Na | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03244982 ↗ |
| Route | Intravenous | “receive either a 250mg or 500mg dose of intravenous fluorescein with their fluorescein angiography procedure.” NCT03244982 ↗ |